Qiagen Operating Margin from 2010 to 2024

QGEN Stock  USD 43.25  0.47  1.10%   
Qiagen NV Operating Profit Margin yearly trend continues to be very stable with very little volatility. Operating Profit Margin is likely to drop to 0.14.
Check Qiagen NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Qiagen NV's main balance sheet or income statement drivers, such as Depreciation And Amortization of 215.6 M, Interest Expense of 50.7 M or Total Revenue of 1 B, as well as many indicators such as Price To Sales Ratio of 6.94, Dividend Yield of 0.0 or PTB Ratio of 2.47. Qiagen financial statements analysis is a perfect complement when working with Qiagen NV Valuation or Volatility modules.
  
Check out the analysis of Qiagen NV Correlation against competitors.
To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.

Latest Qiagen NV's Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of Qiagen NV over the last few years. It is Qiagen NV's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Qiagen NV's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.26 %10 Years Trend
Slightly volatile
   Operating Profit Margin   
       Timeline  

Qiagen Operating Margin Regression Statistics

Arithmetic Mean0.16
Geometric Mean0.14
Coefficient Of Variation47.21
Mean Deviation0.06
Median0.14
Standard Deviation0.08
Sample Variance0.01
Range0.248
R-Value0.68
Mean Square Error0
R-Squared0.46
Significance0.01
Slope0.01
Total Sum of Squares0.08

Qiagen Operating Margin History

2023 0.23
2022 0.25
2021 0.28
2020 0.3
2019 0.22
2018 0.18
2017 0.11

About Qiagen NV Financial Statements

Qiagen NV investors utilize fundamental indicators, such as Operating Margin, to predict how Qiagen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company was founded in 1986 and is headquartered in Venlo, the Netherlands. Qiagen NV operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 6200 people.

Pair Trading with Qiagen NV

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qiagen NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will appreciate offsetting losses from the drop in the long position's value.

Moving together with Qiagen Stock

  0.65A Agilent TechnologiesPairCorr
  0.77ME 23Andme HoldingPairCorr
  0.7VALN Valneva SE ADRPairCorr

Moving against Qiagen Stock

  0.76EWTX Edgewise TherapeuticsPairCorr
  0.74BMY Bristol Myers Squibb Sell-off TrendPairCorr
  0.57EXEL ExelixisPairCorr
  0.52FLGC Flora Growth CorpPairCorr
  0.47KTTAW Pasithea TherapeuticsPairCorr
The ability to find closely correlated positions to Qiagen NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qiagen NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qiagen NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qiagen NV to buy it.
The correlation of Qiagen NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qiagen NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qiagen NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qiagen NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Qiagen NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Qiagen NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Qiagen Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Qiagen Nv Stock:
Check out the analysis of Qiagen NV Correlation against competitors.
To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.255
Earnings Share
0.44
Revenue Per Share
8.841
Quarterly Revenue Growth
0.055
Return On Assets
0.0484
The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.